AzTrials
AzTrials

Aortic Valve StenosisCOMFORTNCT05779787

COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

An observational study of Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement, run by Niguarda Hospital at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
TAVR Aligned and TAVR Random
Type of treatment
Surgery or procedure
How many people
100 participants
Where
1 siteItaly
Study dates
15 Feb 2023to 15 May 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive patients with severe aortic stenosis diagnosed according to ESC guidelines, undergoing transcatheters aortic valve replacement with Navitor valve randomly implanted or Acurate Neo with commisural alignment technique

Who may be able to join

None listed.

Who cannot join

  • Patients excluded in this registry should have all the following criteria:
  • Valve in Valve procedure
  • Hemodynamical instability
  • TAVR performed from other access (not femoral)
  • No-CT Planned TAVR
  • TAVR performed with Chimney Technique

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Giuseooe Esposito, MD contact

+393278393131

giuseppe.esposito@yahoo.com

Italy1 site, 1 recruiting
  • ASST GOM Niguarda

    Milan, Lombardy, 20162

    Giuseppe Esposito, MD, +393278393131, giuseppe.esposito@yahoo.com

    Recruiting

Other trials in Italy

About this study

Official title: COronary Re-EngageMent aFter RandOm NavitoR Alignment (COMFORT STUDY)

Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. This approach allows easy coronary re-engagement through the valve stent frame with a trade off paid of procedure complexity.

Considering the prevalence of coronary artery disease (CAD) and the increasing percentage of younger patients treated with TAVI, investigate whether a simpler procedure with random implantation of Navitor valve is not inferior in terms of coronary re-access, is required The key point of the project will be the evaluation of the feasibility of coronary re-engagement after a Navitor valve randomly implanted.

Read the detailed description

Transcatheter Aortic Valve Implantation (TAVI) is recommended by European and American guidelines to treat patients with aortic stenosis regardless of procedural risk (1, 2). In the last decades the increasing percentage of younger patients treated with TAVI, reflect the extensive indications in lower risk setting, highlighting the importance of easy coronary re-engagement after valve implantation. Considering the prevalence and the progression of a pre-existing coronary artery disease (CAD), the timing of coronary intervention should be accurate selected (3) addressing the percentage of unplanned percutaneous coronary intervention (PCI) after TAVI (4). In fact, while PCI before TAVR was previously recommend despite the uncertain prognostic role (5), recent data remarks the possibility of a postponed coronary intervention using a commissural alignment technique (6) that allows a predictable stent frame position in the sinus of Valsalva (7). Moreover, following the emerging concept of easy re-access, only a few types of prostheses have been shown to have an high degree of stent position predictability after implantation, leading to a limited option in terms of prosthesis choice. Furthermore, to achieve the best results with commissural alignment technique, accurate procedure planning and operator's expertise are required in order to properly manage the valve specific orientation in the aorta with consequent increase in time, radiation and procedure complexity.

However, geometry of the stent frame (height and size) and the anatomical characteristics of patients have to be enlisted as contributory factors to difficult coronary re-engagement and need to be evaluate in order to establish the feasibility of the re-access after TAVR.

The investigators' findings could provide data regarding the non-inferiority rate of coronary cannulation after a simpler procedure with Navitor implantation without alignment technique. Due to these results, the valves portfolio available in patients with coronary artery disease that needed PCI after TAVR, could be larger and various allowing the best protheses choice according to the patient's anatomy and operator's expertise. Finally, knowing the predictors of difficult re-engagement for both types of valves, regardless of implantation technique, could be interesting for an even more valve tailored approach.

The purpose of this study is to investigate the feasibility of coronary re-engagement after randomly (not aligned) Navitor implantation, as already perform in current clinical practice, due to a lower predictable orientation of this type of valve.

Being tested
TAVR Aligned, TAVR Random
Medical subject headings
Aortic Valve Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TAVR AlignedProcedure or surgery

    Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.

  • TAVR RandomProcedure or surgery

    TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used

Study groups in NCT05779787
Study groupRoleWhat they receive
TAVR performed with commissural alignment technique (Aligned Group)Patients with severe aortic stenosis undergoing TAVR procedure performed with commissural alignment technique. We consider in this groups only the Accurate and Accurate Neo 2 Valve which are the first choice due to the best stent frames position predictability with this technique
Receives: Procedure: TAVR Aligned; Procedure: TAVR Random
TAVR performed with random implantation of Navitor valve (Random Group)Patients with severe aortic stenosis undergoing TAVR procedure performed with random implantation of Navitor Valve
Receives: Procedure: TAVR Aligned; Procedure: TAVR Random

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Coronary re-access after TAVR procedure

    Re-engagement of LMCA and RCA after valve implantation is defined as selective cannulation and subsequent selective angiography. All others type of re-engagement will be classify as "non selective". We will stratify also the modality of re-cannulation in relation to the position of the valves' stent struts as "above", "across" and "behind".

    Measured: During procedure

Secondary outcomes (13)
  1. Total Implant Time

    Total time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment Fluoroscopy time + Implantation Fluoroscopy time).

    Measured: During procedure

  2. Total Implant Fluoroscopy Time

    Total Fluoroscopy time required for valve implantation. We count the time from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

    Measured: During procedure

  3. Total Implant Radiations

    Total Radiations required for valve implantation. We count the radiations used from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).

    Measured: During procedure

  4. Total Implant Contrast

    Total Contrast required for valve implantation

    Measured: During procedure

  5. Alignment Radiation

    Radiation required for commissural alignment

    Measured: During procedure

  6. Alignment Fluoroscopy Time

    Fluoroscopy time required for commissural alignment

    Measured: During procedure

  7. Implant Radiation

    Radiation required for valve implantation

    Measured: During procedure

  8. Implant Fluoroscopy Time

    Fluoroscopy time required for valve implantation

    Measured: During procedure

  9. Implant Contrast

    Contrast required for valve implantation

    Measured: During procedure

  10. Re-Engagement Radiation

    Radiation required for re-engagement

    Measured: During procedure

  11. Re-Engagement Fluoroscopy Time

    Fluoroscopy time required for coronary re-engagement

    Measured: During procedure

  12. Re-Engagement Contrast used

    Contrast required for coronary re-engagement

    Measured: During procedure

  13. Re-Engagement Time

    Time required for coronary re-engagement

    Measured: During procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2023
  2. Study start15 Feb 2023
  3. Primary completion15 Feb 2027 (estimated)
  4. Study completion15 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05779787
Sponsor's protocol ID
D001024
Acronym
COMFORT
Status last verified
Apr 2026
First submitted
10 Mar 2023
Last updated
16 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement, run by Niguarda Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Giuseooe Esposito, MD (+393278393131, giuseppe.esposito@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Coronary re-access after TAVR procedure (time frame: During procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
COMFORT Clinical Trial NCT05779787 | AzTrials